WERE AM Mobile App 2020

LISTEN LIVE. LIKE US ON FACEBOOK. FOLLOW US ON TWITTER

Power 107.5
CLOSE

According to nbc4i.com kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.

The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators give the go-ahead.

The Food and Drug Administration was expected to post its independent review of the company’s safety and effectiveness data later in the day.

Advisers to the FDA will publicly debate the evidence next week. If the agency ultimately authorizes the shots, the Centers for Disease Control and Prevention will make the final decision on who should receive them.

Will you be getting your child vaccinated?

Who Is The New Real Housewives Of Potomac Friend, Askale Davis? [PHOTOS]
9 photos